These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 18226947

  • 1. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.
    Quilici S, Abrams KR, Nicolas A, Martin M, Petit C, Lleu PL, Finnern HW.
    Sleep Med; 2008 Oct; 9(7):715-26. PubMed ID: 18226947
    [Abstract] [Full Text] [Related]

  • 2. A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.
    Sun Y, van Valkenhoef G, Morel T.
    Curr Med Res Opin; 2014 Nov; 30(11):2267-78. PubMed ID: 25050588
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
    Giorgi L, Ritchie SY, Kirsch JM.
    Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.
    Partinen M, Hirvonen K, Jama L, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.
    Sleep Med; 2006 Aug; 7(5):407-17. PubMed ID: 16815748
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
    Inoue Y, Hirata K, Kuroda K, Fujita M, Shimizu T, Emura N, Uchimura N, Kagimura T, Sha K, Nozawa T.
    Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
    [Abstract] [Full Text] [Related]

  • 6. Long-term open-label study of pramipexole in patients with primary restless legs syndrome.
    Inoue Y, Kuroda K, Hirata K, Uchimura N, Kagimura T, Shimizu T.
    J Neurol Sci; 2010 Jul 15; 294(1-2):62-6. PubMed ID: 20451927
    [Abstract] [Full Text] [Related]

  • 7. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.
    Montplaisir J, Karrasch J, Haan J, Volc D.
    Mov Disord; 2006 Oct 15; 21(10):1627-35. PubMed ID: 16874755
    [Abstract] [Full Text] [Related]

  • 8. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
    Giorgi L, Asgharian A, Hunter B.
    Clin Ther; 2013 Sep 15; 35(9):1321-36. PubMed ID: 23938061
    [Abstract] [Full Text] [Related]

  • 9. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome.
    Garcia-Borreguero D, Grunstein R, Sridhar G, Dreykluft T, Montagna P, Dom R, Lainey E, Moorat A, Roberts J.
    Sleep Med; 2007 Nov 15; 8(7-8):742-52. PubMed ID: 17512789
    [Abstract] [Full Text] [Related]

  • 10. Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study).
    Partinen M, Hirvonen K, Jama L, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.
    Sleep Med; 2008 Jul 15; 9(5):537-41. PubMed ID: 18276187
    [Abstract] [Full Text] [Related]

  • 11. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
    Prescrire Int; 2006 Oct 15; 15(85):173-6. PubMed ID: 17128523
    [Abstract] [Full Text] [Related]

  • 12. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
    Walters AS, Ondo WG, Dreykluft T, Grunstein R, Lee D, Sethi K, TREAT RLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group.
    Mov Disord; 2004 Dec 15; 19(12):1414-23. PubMed ID: 15390050
    [Abstract] [Full Text] [Related]

  • 13. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.
    Ferini-Strambi L, Aarskog D, Partinen M, Chaudhuri KR, Sohr M, Verri D, Albrecht S.
    Sleep Med; 2008 Dec 15; 9(8):874-81. PubMed ID: 18952497
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study).
    Oertel WH, Stiasny-Kolster K, Bergtholdt B, Hallström Y, Albo J, Leissner L, Schindler T, Koester J, Reess J, Pramipexole RLS Study Group.
    Mov Disord; 2007 Jan 15; 22(2):213-9. PubMed ID: 17133582
    [Abstract] [Full Text] [Related]

  • 15. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
    Allen RP, Ritchie SY.
    Sleep Med; 2008 Dec 15; 9(8):899-902. PubMed ID: 18024167
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial.
    Ma JF, Wan Q, Hu XY, Sun SG, Wang WZ, Zhao ZX, Wang YJ, Liu CF, Li JM, Jiang YP, Chen SD.
    Sleep Med; 2012 Jan 15; 13(1):58-63. PubMed ID: 22137119
    [Abstract] [Full Text] [Related]

  • 17. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
    Jama L, Hirvonen K, Partinen M, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.
    Sleep Med; 2009 Jun 15; 10(6):630-6. PubMed ID: 19171500
    [Abstract] [Full Text] [Related]

  • 18. Critical review of ropinirole and pramipexole - putative dopamine D(3)-receptor selective agonists - for the treatment of RLS.
    Varga LI, Ako-Agugua N, Colasante J, Hertweck L, Houser T, Smith J, Watty AA, Nagar S, Raffa RB.
    J Clin Pharm Ther; 2009 Oct 15; 34(5):493-505. PubMed ID: 19744006
    [Abstract] [Full Text] [Related]

  • 19. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL, Freeman A, Ingram CD, Rye DB, Chakravorty S, Watts RL.
    Sleep Med; 2005 Mar 15; 6(2):141-7. PubMed ID: 15716217
    [Abstract] [Full Text] [Related]

  • 20. Proposed dose equivalence between clonazepam and pramipexole in patients with restless legs syndrome.
    Shinno H, Oka Y, Otsuki M, Tsuchiya S, Mizuno S, Kawada S, Innami T, Sasaki A, Hineno T, Sakamoto T, Inami Y, Nakamura Y, Horiguchi J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):522-6. PubMed ID: 20156514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.